Replies to post #814721 on Sizzling Stock Picks

[BottomBounce]

CANCER $TYME "We are excited to collaborate on this new effort to help uncover key findings about how specific biomarkers may help slow the development of certain cancer types," said Diane Simeone, MD, Director of the Pancreatic Cancer Center at NYU Langone Health's Perlmutter Cancer Center and Lead Principle Investigator for the Pancreatic Cancer Network's Precision Promise(SM) trials. "We believe our translational research can help affect future development of SM-88 and broaden our understanding of this novel approach by targeting cancer metabolism."